Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced the pricing of a registered direct offering (the “Offering”) to ...

Abstract: Diabetic retinopathy (DR) poses a significant risk of vision loss due to diabetes-related damage to retinal blood vessels. Early detection and analysis of DR progression are crucial for ...